Speciality Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Education Dialogues
    • Business Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Speciality Medical Dialogues
    • Editorial
    • News
        • Anesthesiology
        • Cancer
        • Cardiac Sciences
        • Critical Care
        • Dentistry
        • Dermatology
        • Diabetes and Endo
        • Diagnostics
        • ENT
        • Featured Research
        • Gastroenterology
        • Geriatrics
        • Medicine
        • Nephrology
        • Neurosciences
        • Nursing
        • Obs and Gynae
        • Ophthalmology
        • Orthopaedics
        • Paediatrics
        • Parmedics
        • Pharmacy
        • Psychiatry
        • Pulmonology
        • Radiology
        • Surgery
        • Urology
    • Practice Guidelines
        • Anesthesiology Guidelines
        • Cancer Guidelines
        • Cardiac Sciences Guidelines
        • Critical Care Guidelines
        • Dentistry Guidelines
        • Dermatology Guidelines
        • Diabetes and Endo Guidelines
        • Diagnostics Guidelines
        • ENT Guidelines
        • Featured Practice Guidelines
        • Gastroenterology Guidelines
        • Geriatrics Guidelines
        • Medicine Guidelines
        • Nephrology Guidelines
        • Neurosciences Guidelines
        • Obs and Gynae Guidelines
        • Ophthalmology Guidelines
        • Orthopaedics Guidelines
        • Paediatrics Guidelines
        • Psychiatry Guidelines
        • Pulmonology Guidelines
        • Radiology Guidelines
        • Surgery Guidelines
        • Urology Guidelines
    LoginRegister
    Speciality Medical Dialogues
    LoginRegister
    • Home
    • Editorial
    • News
      • Anesthesiology
      • Cancer
      • Cardiac Sciences
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endo
      • Diagnostics
      • ENT
      • Featured Research
      • Gastroenterology
      • Geriatrics
      • Medicine
      • Nephrology
      • Neurosciences
      • Nursing
      • Obs and Gynae
      • Ophthalmology
      • Orthopaedics
      • Paediatrics
      • Parmedics
      • Pharmacy
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
    • Practice Guidelines
      • Anesthesiology Guidelines
      • Cancer Guidelines
      • Cardiac Sciences Guidelines
      • Critical Care Guidelines
      • Dentistry Guidelines
      • Dermatology Guidelines
      • Diabetes and Endo Guidelines
      • Diagnostics Guidelines
      • ENT Guidelines
      • Featured Practice Guidelines
      • Gastroenterology Guidelines
      • Geriatrics Guidelines
      • Medicine Guidelines
      • Nephrology Guidelines
      • Neurosciences Guidelines
      • Obs and Gynae Guidelines
      • Ophthalmology Guidelines
      • Orthopaedics Guidelines
      • Paediatrics Guidelines
      • Psychiatry Guidelines
      • Pulmonology Guidelines
      • Radiology Guidelines
      • Surgery Guidelines
      • Urology Guidelines
    • Home
    • Practice Guidelines
    • ENT Guidelines
    • Cervical...

    Cervical Lymphadenopathy - Standard Treatment Guidelines

    Written by supriya kashyap kashyap Published On 2018-05-27T19:01:09+05:30  |  Updated On 18 Aug 2021 4:43 PM IST

    Lymphadenopathy is an abnormal increase in size and/ or altered consistency of lymph nodes. It is a clinical manifestation of regional or systemic disease and serves as an excellent clue to the underlying disease. Cervical lymphadenopathy (C.L.) is a fairly common clinical presentation.


    Ministry of Health and Family Welfare, Government of India has issued the Standard Treatment Guidelines for Cervical Lymphadenopathy. Following are the major recommendations:



    Surgical anatomy and classification :


    Cervical lymph nodes are lymph nodes found in the neck. There are approximately 300 lymph nodes in the neck


    Cervical lymph nodes are classifieds into 7 groups. They are-




    • Level I: Submental and submandibular nodes


    o Level Ia: Submental triangle


    o Level Ib: Submandibular triangle




    • Level II: Upper jugular nodes

    • Level III: Middle jugular nodes

    • Level IV: Lower jugular nodes

    • Level V: Posterior triangle group

    • Level VI: Pre-tracheal, pre-laryngeal and post-tracheal

    • Level VII: Mediastinal




    Incidence


    - Age < 30 - 79% benign; 15% lymphomatous; 6% carcinomas


    - Age > 50 - 40% benign; 16% lymphomatous; 44% carcinomas


    - 0.6 annual incidence of generalized lymphadenopathy



    Differential diagnosis


    Common infectious causes of lymphadenopathy


    1. Adenovirus


    2. CMV


    3. Enterovirus


    4. EBV


    5. Varicella


    6. Herpes simplex


    7. Staphlococcus infection


    8. Group A hemolytic Streptococcus


    9. Tularemia


    10. Brucellocis


    11. Tuberculosis


    12. Atypical mycobacteria


    13. Klebsilla


    14. AIDS


    15. Bubonic plague


    16. Anthrax


    Common non-infectious causes of lymphadenopathy


    1. Hodgkin's disease


    2. Lymphomas


    3. Leukemia


    4. Metastatic disease


    5. Histiocytosis


    6. SLE and JRA


    7. Kawasaki Disease


    8. Sarcoidosis



    Symptoms and signs :


    1. Neck Swelling


    Lymph node character


    i) Stone hard: typical of cancer usually metastatic


    ii) Firm rubbery: can suggest lymphoma


    iii) Soft: infection or inflammation


    iv) Matting: tubercular


    2. Pain-


    (i) Painful lymph node present in acute inflammatory condition.


    (ii) Painless lymph node mainly present in granulomatous or malignant conditions


    3. Size - Rapid increase in size could be due to malignancy.



    Evaluation


    1. Laboratory studies




    • CBC count, including a careful evaluation of the peripheral blood smear. An erythrocyte sedimentation rate is nonspecific but may be helpful.

    • Evaluation of hepatic and renal function and a urine analysis are useful to identify underlying systemic disorders that may be associated with lymphadenopathy.

    • Additional studies, such as lactate dehydrogenase (LDH), uric acid, calcium, and phosphate, may be indicated if malignancy is suspected. Skin testing for tuberculosis is usually indicated.

    • In evaluating specific regional adenopathy, lymph node aspirate for culture may be important if lymphadenitis is clinically suspected.

    • Titers for specific microorganisms may be indicated, particularly if generalized adenopathy is present. These may include Epstein-Barr virus, cytomegalovirus (CMV), Toxoplasma species, and human immunodeficiency virus (HIV).


    2. Imaging studies




    • Chest radiography is usually the primary screening imaging study. Additional imaging studies are usually based on abnormal chest radiograph findings. Chest radiography is often helpful in elucidating mediastinal adenopathy and underlying diseases affecting the lungs, including tuberculosis, coccidioidomycosis, lymphomas.

    • CT scan and MRI especially helpful in case of metastatic disease to know the extent of involvement.

    • Nuclear medicine scanning is helpful in the evaluation of lymphomas.

    • Ultrasonography may be helpful in evaluating the changes in the lymph nodes and in evaluating the extent of lymph node involvement in patients with lymphadenopathy.


    3. Fine Needle aspiration Cytology


    4. Lymph Node Biopsy / Excisional Biopsy



    Management


    1. Treatment with antibiotics (covering the bacterial pathogens frequently implicated in lymphadenitis) followed by re-evaluation in 2-4 weeks is reasonable if clinical findings suggest lymphadenitis. Benign reactive adenopathy may be safely observed for months. Infectious lymph adenopathy usually requires treatment with appropriate antibiotics.


    2. Granulomatous condition requires address of general condition, and treatment with steroids and immunoglobins depending on conditions.


    3. In cases of malignant conditions, patient can be managed on different modality of treatment viz chemotherapy, radiotherapy or surgery depending on type and stage of malignancy.



    Guidelines by The Ministry of Health and Family Welfare :


    Dr J M Hans Ex-HOD Dept. of Otorhinolaryngology Dr.RML Hospital New Delhi

    Government of IndiaMinistry of Health and Family WelfareStandard Treatment Guidelines

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    supriya kashyap kashyap
    supriya kashyap kashyap
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 12 Oct 2022 7:06 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok